FDA asks Allergan to withdraw eye drug sales aid
Thu, 08 Sep 2005 04:57 PM EST
... WASHINGTON (Reuters) - The Food and Drug Administration has asked Allergan Inc. to withdraw promotional material for its Lumigan eyedrops to treat glaucoma because the sales aid is misleading, according to a letter made public on Thursday. ...
Related Topics
- Drug Safety
- Pink Eye
- Eye Care
- Melanoma, Intraocular
- Cyclosporine Ophthalmic
- Eye exercises
- Lasik Eye Surgery
- Eye Diseases
- Financial Aid
- Drug and Medical Device Safety
- Amblyopia
- First Aid
- Prescription Drugs
- Floaters
- Eye Cancer
- Eye Injuries
- Drug Side Effects
- Financial Aid/issues
- Drug Abuse
- Drug Information

Not Signed In -


